TAC1 and autosomal dominant polycystic kidney disease: These effects are mediated by activation of the classical NKA signaling pathway, involving Src, EGFR, MEK, and downregulation of cell cycle dependent kinases, which are already abnormally active in ADPKD (Jansson et al., 2013).